Re: Two Courses of Intravesical Bacillus Calmette-Guerin for Transitional Cell Carcinoma of the Bladder, by E. O. Haaff, S. M. Dresner, T. L. Ratliff and W. J. Catalona, J. Urol., 136: 820–824, 1986

1987 ◽  
Vol 138 (2) ◽  
pp. 409-410 ◽  
Author(s):  
Harry W. Herr
2000 ◽  
pp. 1124-1129 ◽  
Author(s):  
DONALD L. LAMM &NA; &NA; ◽  
BRENT A. BLUMENSTEIN ◽  
JOHN D. CRISSMAN ◽  
JAMES E. MONTIE ◽  
JAMES E. GOTTESMAN ◽  
...  

Author(s):  
Vikram M. Narayan

This study summarizes the landmark study assessing the value of maintenance intravesical Bacillus Calmette Guerin (BCG) to reduce the risk for recurrence or progression of high-grade superficial or carcinoma in situ (CIS) transitional cell carcinoma of the bladder. The trial randomized patients with completely resected noninvasive urothelial cell carcinoma at high risk of recurrence to BCG induction alone versus BCG induction plus maintenance therapy in the form of six weekly treatments. The study found that maintenance BCG reduces disease-specific recurrence and may also reduce the rate of disease progression.


1986 ◽  
Vol 136 (4) ◽  
pp. 820-823 ◽  
Author(s):  
Eric O. Haaff ◽  
Steven M. Dresner ◽  
Timothy L. Ratliff ◽  
William J. Catalona

Sign in / Sign up

Export Citation Format

Share Document